Which Destinations Require the Directed Dual-Use Licence for Xylene - A Country Table

Commercial xylene is supplied as mixed xylene, CAS 1330-20-7, or as the isolated isomers ortho-xylene CAS 95-47-6, meta-xylene CAS 108-38-3, and para-xylene CAS 106-42-3. Mixed xylene composition is feedstock-dependent: catalytic reformate-derived material typically contains 40–50 % meta-xylene, 15–20 % ortho-xylene, 18–20 % para-xylene, and 15–20 % ethylbenzene. The physical parameters relevant to shipment screening include a density range of 0.86–0.88 g/cm³ at 20 °C, a closed-cup flash point of 25–32 °C, and an atmospheric boiling range of 138–144 °C. Mixed xylene falls under HS heading 2902.44; the individual isomer grades fall under HS 2902.41 through 2902.43. The product is not a listed item in Annex I of Regulation (EU) 2021/821. Consequently, no destination requires the directed dual-use licence for xylene solely on the basis of the commodity code. A directed dual-use licence is transaction-specific and arises when the exporter is informed by a competent authority under Article 4 or Article 5 of Regulation (EU) 2021/821 that a particular consignment may be intended for a weapons of mass destruction end-use or a military end-use in a sanctioned destination.

Why does an unlisted solvent enter the directed dual-use licensing system?

The control mechanism is the end-use catch-all. Under Article 4(1) of Regulation (EU) 2021/821, an authorisation may be required for non-listed items if the exporter has been informed by the competent authority. Under Article 5, an authorisation may be required where the exporter has grounds for suspicion. The relevant international obligation is United Nations Security Council Resolution 1540, which obliges UN member states to adopt controls on chemical intermediates that may be diverted to chemical weapons programmes even when the chemical itself is not scheduled under the Chemical Weapons Convention. Xylene is not listed in Schedule 1, Schedule 2, or Schedule 3 of the Chemical Weapons Convention, but its function as an organic diluent and solvent in multi-stage synthesis means that a competent authority may direct a licence for a specific volume, named consignee, and declared end-use location. The directed dual-use licence is not a product-generic permission; it is an individual transaction control with a named end-user, a declared tonnage, and a fixed port of discharge.

For day-to-day export operations, the trigger is the written notice, not the destination alone. A 20,000 L isotank of mixed xylene consigned to a solvent-blending terminal in Rotterdam does not engage the directed dual-use licence mechanism absent a competent-authority notice. The same grade shipped in 200 L drums to a research institute in a high-risk jurisdiction may require a directed licence if the authority has information of diversion risk. Exporters should screen the end-user, the end-use statement, the transport route, and the sanctions list before relying on an open general licence or a general export authorisation. The operational boundary is clear: once a notice under Article 4 is received, the shipment cannot be cleared under a general authorisation and a transaction-specific licence is mandatory.

When the consignee address falls inside an embargoed or sanctioned territory

The table below identifies destinations where the EU, UK, or UN sanctions framework creates a higher probability that a directed dual-use licence will be required for xylene. The table is a risk-screening matrix, not a legal statement that xylene is prohibited. Because xylene is unlisted in Annex I of Regulation (EU) 2021/821, the licence trigger is normally the end-use notice or the destination-specific dual-use provision applied through national measures.

The table does not establish an automatic obligation for every xylene shipment. A solvent consignment to a civilian pharmaceutical packaging plant in Tehran may still receive a licence if the end-use documentation demonstrates civilian use and the consignee is not a listed entity. Conversely, a shipment to a non-listed destination may require a directed dual-use licence if the exporter receives an Article 4 notice. Published data for specific configurations is limited; the exporter must consult the consolidated list of sanctions and the live licensing notice before shipment.

Documentary requirements for directed licence applications involving xylene

The directed licence application for xylene typically requires the commercial transaction documents: supplier and consignee details, end-use statement, quantity in kilograms and litres, CAS number, HS code, transport route, and a copy of the safety data sheet. Where the destination appears in the country table, the competent authority may also require an end-user certificate issued by the foreign government or chamber of commerce, a delivery verification clause, and a contractual prohibition on re-export without prior authorisation. The application is assessed under Regulation (EU) 2021/821 Article 8 where national measures supplement the EU framework. Processing times are not uniform; exporters should not assume a general authorisation is available for a transaction once the destination or end-use indicator triggers the directed licence.

Trans-shipment through a freeport or bonded warehouse does not terminate the licensing obligation. If the xylene is unloaded in a Gulf trans-shipment hub but the declared ultimate consignee is located in Iran, the competent authority will treat the transaction as an export to Iran for licensing purposes. Bills of lading that omit the ultimate destination or list only a freight forwarder are not sufficient to avoid the directed licence. In some cases, the licence condition will require the master bill of lading to state the final place of discharge and include a no-transfer clause.

Solvent grade parameters and customs classification checks

Mixed xylene is traded under CAS 1330-20-7 and HS 2902.44. The isomer-specific codes are HS 2902.41 for o-xylene, HS 2902.42 for m-xylene, and HS 2902.43 for p-xylene. The distinction matters because export control authorities may apply different risk profiles to high-purity p-xylene used in polyester fibre production and nitration-grade mixed xylene used in solvent applications. A certificate of analysis should record flash point according to ASTM D56 or ASTM D93, distillation range according to ASTM D850, and aromatic purity by capillary gas chromatography. The exporter should ensure that the CAS and HS code on the commercial invoice match the batch certificate and the safety data sheet under Regulation (EC) No 1907/2006 (REACH) and Regulation (EC) No 1272/2008 (CLP).

End-use diversion indicators that trigger a directed licence for xylene

Competent authorities apply diversion indicators rather than simple destination lists. The indicators include a buyer whose business line is unrelated to the stated solvent application, a request for unusually high purity p-xylene when the downstream process does not require high purity, a delivery address that appears to be a trans-shipment warehouse, and a declared end-use that is inconsistent with the packaging and volume. Under Article 5(1) of Regulation (EU) 2021/821, the exporter is obliged to notify the competent authority when it is aware that the xylene may be intended for a weapons of mass destruction-related end-use. Under Article 27, records of export authorisations and end-user documentation must be retained for at least 5 years, aligning with national customs record-keeping requirements.

The interaction between xylene's drug precursor status and the directed dual-use licence is separate. Under Regulation (EC) No 273/2004 and Council Regulation (EC) No 111/2005, xylene is a Category 3 drug precursor. Exporters must hold the applicable precursor trade and export authorisation for controlled transactions and provide end-use declarations for non-EU destinations. These drug precursor licences are not a substitute for a directed dual-use licence when a competent authority has issued an Article 4 notice. A single consignment may therefore require two parallel authorisations: the drug precursor export authorisation and the directed dual-use licence.